UC Irvine team: Alzheimer's vax shows promise
Research presented this week at the Society for Neuroscience meeting showed one vaccine candidate appears both safe and effective in an animal model. A UC Irvine team tested a vaccine developed against a non-human protein that is similar to amyloid-beta but has a different sequence of amino acids. Because the protein in the vaccine is non-human, it's hoped that the vaccine would not cause inflammation. "The idea is if we can overcome this auto-inflammatory reaction, we might be able to develop a safe vaccine," said the senior author of the study, neuroscientist Charles Glabe of UC Irvine, at a news conference Tuesday in San Diego. Report
More stories about Alzheimer's
Comments
Post new comment
Paid Research Reports
- Commercial Insight: Top 20 Cancer Therapy Brands
- Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issue
- The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
More Research Reports >>
SHARE
WITH: